nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—DRD2—nicotine dependence	0.843	1	CbGaD
Cisapride—HTR3A—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00638	0.0437	CbGpPWpGaD
Cisapride—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00473	0.0324	CbGpPWpGaD
Cisapride—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00381	0.0262	CbGpPWpGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00375	0.0257	CbGpPWpGaD
Cisapride—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00323	0.0221	CbGpPWpGaD
Cisapride—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0032	0.0219	CbGpPWpGaD
Cisapride—HTR4—Monoamine GPCRs—DRD2—nicotine dependence	0.00319	0.0219	CbGpPWpGaD
Cisapride—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00298	0.0204	CbGpPWpGaD
Cisapride—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00293	0.0201	CbGpPWpGaD
Cisapride—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00288	0.0198	CbGpPWpGaD
Cisapride—HTR4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00268	0.0184	CbGpPWpGaD
Cisapride—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00265	0.0182	CbGpPWpGaD
Cisapride—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00263	0.018	CbGpPWpGaD
Cisapride—Iloperidone—DRD2—nicotine dependence	0.00262	0.502	CrCbGaD
Cisapride—Metoclopramide—DRD2—nicotine dependence	0.00259	0.498	CrCbGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00241	0.0166	CbGpPWpGaD
Cisapride—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00236	0.0162	CbGpPWpGaD
Cisapride—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00231	0.0158	CbGpPWpGaD
Cisapride—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00207	0.0142	CbGpPWpGaD
Cisapride—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.002	0.0137	CbGpPWpGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00197	0.0135	CbGpPWpGaD
Cisapride—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00179	0.0123	CbGpPWpGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00173	0.0119	CbGpPWpGaD
Cisapride—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00164	0.0113	CbGpPWpGaD
Cisapride—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00163	0.0112	CbGpPWpGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00157	0.0108	CbGpPWpGaD
Cisapride—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00139	0.00955	CbGpPWpGaD
Cisapride—HTR3A—Ion channel transport—GABRA4—nicotine dependence	0.00138	0.00949	CbGpPWpGaD
Cisapride—HTR3A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00137	0.00938	CbGpPWpGaD
Cisapride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00133	0.0091	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—TAS2R16—nicotine dependence	0.00132	0.00905	CbGpPWpGaD
Cisapride—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00131	0.00898	CbGpPWpGaD
Cisapride—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00125	0.0086	CbGpPWpGaD
Cisapride—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00122	0.00834	CbGpPWpGaD
Cisapride—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0012	0.00824	CbGpPWpGaD
Cisapride—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00108	0.00738	CbGpPWpGaD
Cisapride—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00107	0.00737	CbGpPWpGaD
Cisapride—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00105	0.00723	CbGpPWpGaD
Cisapride—HTR4—brain—nicotine dependence	0.00105	0.188	CbGeAlD
Cisapride—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00101	0.00694	CbGpPWpGaD
Cisapride—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000986	0.00676	CbGpPWpGaD
Cisapride—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000981	0.00673	CbGpPWpGaD
Cisapride—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000969	0.00664	CbGpPWpGaD
Cisapride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000959	0.00658	CbGpPWpGaD
Cisapride—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000948	0.0065	CbGpPWpGaD
Cisapride—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000947	0.00649	CbGpPWpGaD
Cisapride—HTR3A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000912	0.00626	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.000906	0.00621	CbGpPWpGaD
Cisapride—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.000878	0.00602	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.000859	0.00589	CbGpPWpGaD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000852	0.00585	CbGpPWpGaD
Cisapride—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00085	0.00583	CbGpPWpGaD
Cisapride—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000831	0.0057	CbGpPWpGaD
Cisapride—HTR3A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000828	0.00568	CbGpPWpGaD
Cisapride—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00082	0.00563	CbGpPWpGaD
Cisapride—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000796	0.00546	CbGpPWpGaD
Cisapride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000778	0.00534	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000745	0.00511	CbGpPWpGaD
Cisapride—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000742	0.00509	CbGpPWpGaD
Cisapride—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000738	0.00506	CbGpPWpGaD
Cisapride—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000732	0.00502	CbGpPWpGaD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00073	0.00501	CbGpPWpGaD
Cisapride—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000682	0.00468	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—TAS2R16—nicotine dependence	0.000677	0.00464	CbGpPWpGaD
Cisapride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000676	0.00464	CbGpPWpGaD
Cisapride—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000674	0.00462	CbGpPWpGaD
Cisapride—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000673	0.00462	CbGpPWpGaD
Cisapride—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000667	0.00458	CbGpPWpGaD
Cisapride—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000632	0.00434	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.000621	0.00426	CbGpPWpGaD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000616	0.00423	CbGpPWpGaD
Cisapride—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000609	0.00418	CbGpPWpGaD
Cisapride—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000606	0.00416	CbGpPWpGaD
Cisapride—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000601	0.00412	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.000595	0.00408	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—FGD1—nicotine dependence	0.000585	0.00401	CbGpPWpGaD
Cisapride—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000578	0.00396	CbGpPWpGaD
Cisapride—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000574	0.00394	CbGpPWpGaD
Cisapride—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.000571	0.00392	CbGpPWpGaD
Cisapride—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00057	0.00391	CbGpPWpGaD
Cisapride—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000564	0.00387	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—OPRM1—nicotine dependence	0.000556	0.00381	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.000553	0.0038	CbGpPWpGaD
Cisapride—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000553	0.00379	CbGpPWpGaD
Cisapride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000548	0.00376	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—FGD1—nicotine dependence	0.000531	0.00364	CbGpPWpGaD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000528	0.00362	CbGpPWpGaD
Cisapride—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.000524	0.00359	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000518	0.00355	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000514	0.00352	CbGpPWpGaD
Cisapride—HTR3A—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000482	0.0033	CbGpPWpGaD
Cisapride—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000468	0.00321	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.000451	0.00309	CbGpPWpGaD
Cisapride—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000448	0.00308	CbGpPWpGaD
Cisapride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000446	0.00306	CbGpPWpGaD
Cisapride—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00044	0.00302	CbGpPWpGaD
Cisapride—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000438	0.00301	CbGpPWpGaD
Cisapride—HTR2B—cardiovascular system—nicotine dependence	0.000437	0.078	CbGeAlD
Cisapride—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000423	0.0029	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000418	0.00287	CbGpPWpGaD
Cisapride—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000417	0.00286	CbGpPWpGaD
Cisapride—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000413	0.00283	CbGpPWpGaD
Cisapride—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000407	0.00279	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—DRD2—nicotine dependence	0.000402	0.00276	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TAS2R16—nicotine dependence	0.0004	0.00274	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.000397	0.00272	CbGpPWpGaD
Cisapride—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00038	0.0026	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000369	0.00253	CbGpPWpGaD
Cisapride—HTR2C—midbrain—nicotine dependence	0.000363	0.0649	CbGeAlD
Cisapride—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000363	0.00249	CbGpPWpGaD
Cisapride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000362	0.00248	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.000361	0.00247	CbGpPWpGaD
Cisapride—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000358	0.00245	CbGpPWpGaD
Cisapride—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000353	0.00242	CbGpPWpGaD
Cisapride—KCNH2—cardiovascular system—nicotine dependence	0.000348	0.0622	CbGeAlD
Cisapride—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000343	0.00235	CbGpPWpGaD
Cisapride—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000339	0.00232	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000334	0.00229	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000319	0.00219	CbGpPWpGaD
Cisapride—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000315	0.00216	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000314	0.00216	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—FGD1—nicotine dependence	0.000314	0.00215	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000312	0.00214	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000311	0.00213	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000309	0.00212	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000294	0.00202	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000293	0.00201	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000291	0.002	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00029	0.00199	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000287	0.00197	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000287	0.00197	CbGpPWpGaD
Cisapride—CYP2B6—cardiovascular system—nicotine dependence	0.000286	0.0511	CbGeAlD
Cisapride—HTR4—Signaling by GPCR—OPRM1—nicotine dependence	0.000285	0.00196	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000284	0.00195	CbGpPWpGaD
Cisapride—HTR3A—brain—nicotine dependence	0.000284	0.0507	CbGeAlD
Cisapride—CYP2C9—cardiovascular system—nicotine dependence	0.000283	0.0506	CbGeAlD
Cisapride—CYP2A6—brain—nicotine dependence	0.000279	0.0498	CbGeAlD
Cisapride—HTR4—Signaling Pathways—AKR1B10—nicotine dependence	0.000277	0.0019	CbGpPWpGaD
Cisapride—DRD2—midbrain—nicotine dependence	0.000276	0.0493	CbGeAlD
Cisapride—KCNH2—midbrain—nicotine dependence	0.000272	0.0486	CbGeAlD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00027	0.00185	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000266	0.00182	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000264	0.00181	CbGpPWpGaD
Cisapride—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000257	0.00176	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000249	0.00171	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000245	0.00168	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000242	0.00166	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000238	0.00163	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000236	0.00162	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000234	0.00161	CbGpPWpGaD
Cisapride—HTR2A—cardiovascular system—nicotine dependence	0.000233	0.0417	CbGeAlD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000231	0.00159	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00023	0.00157	CbGpPWpGaD
Cisapride—HTR2C—brain—nicotine dependence	0.000228	0.0408	CbGeAlD
Cisapride—HTR4—GPCR downstream signaling—DRD2—nicotine dependence	0.000227	0.00156	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000218	0.0015	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000214	0.00147	CbGpPWpGaD
Cisapride—HTR2B—brain—nicotine dependence	0.000214	0.0383	CbGeAlD
Cisapride—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000208	0.00143	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000208	0.00143	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000207	0.00142	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—DRD2—nicotine dependence	0.000206	0.00142	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000205	0.00141	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000204	0.0014	CbGpPWpGaD
Cisapride—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000204	0.0014	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000201	0.00138	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.00134	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000195	0.00134	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000192	0.00132	CbGpPWpGaD
Cisapride—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000189	0.0013	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000189	0.0013	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.00128	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000186	0.00128	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000185	0.00127	CbGpPWpGaD
Cisapride—HTR2A—midbrain—nicotine dependence	0.000182	0.0325	CbGeAlD
Cisapride—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000176	0.00121	CbGpPWpGaD
Cisapride—DRD2—brain—nicotine dependence	0.000173	0.031	CbGeAlD
Cisapride—KCNH2—brain—nicotine dependence	0.000171	0.0305	CbGeAlD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000169	0.00116	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—OPRM1—nicotine dependence	0.000169	0.00116	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000168	0.00115	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000167	0.00115	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000163	0.00112	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000161	0.0011	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000158	0.00108	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000157	0.00108	CbGpPWpGaD
Cisapride—CYP2C8—brain—nicotine dependence	0.000156	0.0279	CbGeAlD
Cisapride—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000155	0.00107	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000153	0.00105	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000148	0.00102	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000146	0.001	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000145	0.000996	CbGpPWpGaD
Cisapride—CYP2B6—brain—nicotine dependence	0.00014	0.0251	CbGeAlD
Cisapride—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000127	0.000873	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000127	0.000869	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000123	0.000846	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000123	0.000845	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000836	CbGpPWpGaD
Cisapride—HTR2A—brain—nicotine dependence	0.000114	0.0204	CbGeAlD
Cisapride—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000112	0.000768	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.000767	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.000758	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.000754	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000109	0.000746	CbGpPWpGaD
Cisapride—CYP2D6—brain—nicotine dependence	0.000104	0.0186	CbGeAlD
Cisapride—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	9.95e-05	0.000683	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—FGD1—nicotine dependence	9.94e-05	0.000682	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP2A7—nicotine dependence	9.77e-05	0.00067	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	9.04e-05	0.00062	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP2A7—nicotine dependence	8.96e-05	0.000615	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	8.92e-05	0.000612	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.78e-05	0.000602	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	8.78e-05	0.000602	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.77e-05	0.000602	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.64e-05	0.000593	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.63e-05	0.000592	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	8.1e-05	0.000556	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.97e-05	0.000547	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	7.85e-05	0.000538	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.75e-05	0.000531	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—WASF2—nicotine dependence	7.66e-05	0.000526	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.62e-05	0.000523	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—WASF1—nicotine dependence	7.35e-05	0.000504	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP2A7—nicotine dependence	7.23e-05	0.000496	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	7.19e-05	0.000494	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP2A7—nicotine dependence	7.06e-05	0.000485	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	6.62e-05	0.000454	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	6.53e-05	0.000448	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	6.25e-05	0.000429	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—WASF2—nicotine dependence	6.18e-05	0.000424	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP2A7—nicotine dependence	6.12e-05	0.00042	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—WASF1—nicotine dependence	5.93e-05	0.000407	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.67e-05	0.000389	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP2A7—nicotine dependence	5.46e-05	0.000375	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.46e-05	0.000374	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—WASF2—nicotine dependence	5.37e-05	0.000368	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	5.34e-05	0.000366	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.23e-05	0.000359	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.15e-05	0.000353	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP2A7—nicotine dependence	5.02e-05	0.000345	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP2A7—nicotine dependence	4.98e-05	0.000342	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD2—nicotine dependence	4.78e-05	0.000328	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.71e-05	0.000323	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.64e-05	0.000318	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP2A7—nicotine dependence	4.26e-05	0.000292	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.86e-05	0.000265	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.35e-05	0.00023	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP2A7—nicotine dependence	3.28e-05	0.000225	CbGpPWpGaD
